PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
During the October 2011 reprogramming cycle, funds were inadvertently moved into CDC's WHO agreement when in fact the intended action was to move funds into USAID's WHO agreement. That prior mistake is being corrected in this August 2012 reprogramming cycle.
The program is aimed to decrease TB burden in Ukraine with focus on TB/HIV by providing technical assistance to the Ministry of Health, the recipients of the Global Fund Round 9 TB grant and other partner organizations in implementation of TB/HIV and MDR-TB activities based on WHO guidelines and recommendations.
The program will improve TB/HIV collaborative mechanisms by providing support in revision of national TB/HIV guidelines with defined responsibilities of each service; providing support in elaborating national TB/HIV strategic plan; revising cross-training curricula for TB and HIV specialists; improving policy environment among local organizations to implement HIV and TB/HIV activities; providing technical assistance in establishing well-functioning information exchange system between TB and HIV programs; promoting and providing assistance in implementation of integrated services and the 3 Is approach.
The program will assist and coordinate countrywide TB drug resistant survey (DRS) through development of survey protocol, training, coordination meetings, procurement of laboratory commodities, transport of commodities and biological samples, monitoring and supervision.
The program will improve MDR-TB management through revising and updating National MDR-TB Strategic Plan and providing technical assistance in improving policy for MDR-TB programmatic management; maintaining policy dialogue to ensure uninterrupted free of charge second line drug supply for all drug resistant TB patients; providing techni
Significant progress has been made in streamlining tuberculosis (TB) control in Ukraine towards international standards. Initial achievements focused on piloting the DOTS Strategy in Donetsk region with support of USAID and WHO were then rolled out to additional 10 oblasts with USAID support. As a result, the Stop TB Strategy including DOTS was endorsed as a country policy through the approval by the Ministry of Health of the National TB Programme 2007-2011.
However, implementation of the Stop TB Strategy in Ukraine remains of low quality and disease indicators fall largely short (59% treatment success rate in 2009) of the global Millennium Development Goals (MDG) targets (85% treatment success rate). Of particular concern are the high levels of MDR-TB (16% and 50% in newly-detected and previously-treated TB cases respectively). While reliable data on extensively drug resistant XDR-TB are unavailable, one study indicates its prevalence around 15% among MDR-TB cases. The overlapping risk factors for TB and HIV have resulted in a steady rise of people living with HIV, among whom TB is leading cause of morbidity and mortality, and HIV-related TB (TB/HIV).
In 2009, 11% of the TB patients reported to WHO were HIV-positive; however, only 86% of the new TB cases notified to WHO knew their HIV status, suggesting that HIV prevalence among TB patients might be higher than as reported above. USAID and WHO have longstanding successful collaboration in Ukraine and, through this project, WHO seeks to reduce a number of critical health systems barriers for prevention, treatment and care of TB/HIV and MDR- TB. All proposed interventions are complementary to USAID-supported activities implemented by other partners, and are built on the experience from previous USAID-supported projects.
For GHCS-USAID Funds: This is a top-up to expand the work being undertaken by WHO.
During FY 2012, the WHO will continue to support the achievement of goals and benchmarks outlined in new Ukraine's National TB Control Plan, 2011 -2016. Expected results for the National TB Program include decreases in TB morbidity in 5%; decreases in TB mortality rate in 10 %; increase access to high quality DOTS services and provision of quality treatment to MDR TB patients.
The focus on FY 2013 activities is on the integration of TB with HIV services. Activities include TB/HIV and HIV testing services, including the development of regional laboratory services and a supporting quality improvement/ quality assurance mentoring program. WHO will assess the implementation of a provider-initiated testing and counseling model in the Zakarpattia oblast. Other activities include the development and testing of a tool to guide services integration, and will be implemented in the oblasts that are implementing health care reform and service integration. WHO will provide assistance in TB/HIV infection control, with operational research on infection control effectiveness to guide the development of national guidelines, and the piloting of models for integrated treatment and care services for HIV-infected pregnant injecting drug users. In addition, WHO will strengthen the capacity of narcological services to deliver HIV prevention services for MARPs, which will include an assessment of narcological services capacity to delivery comprehensive TB/HIV and prevention services for MARPs.
All proposed technical assistance is complementary to USAID-supported activities. These include the TB/HIV project that is under procurement, the TBD comprehensive services targeted to MARPs, which is also under procurement, and the HIV Pledge activity implemented by UNODC.
